Guangdong Province Releases List of Urgent Clinical Drugs and Devices for GBA Cities

Guangdong Province Releases List of Urgent Clinical Drugs and Devices for GBA Cities

The medical products administration and health commission of Guangdong province have released a list of clinically urgent drugs and medical devices from Hong Kong and Macau for the Guangdong-Hong Kong-Marco Greater Bay Area (GBA), which includes nine mainland cities: Guangzhou, Shenzhen, Zhuhai, Foshan, Huizhou, Dongguan, Zhongshan, Jiangmen, and Zhaoqing.

Eligibility Criteria for Medical Institutions in GBA Cities
Medical institutions in these cities are eligible to import and use these urgently needed, Hong Kong and Macau-listed drugs and devices if they meet specific conditions, including being established by Hong Kong and Macao medical providers, having the necessary technical capabilities, and adhering to storage and emergency response requirements.

The List of Urgent Clinical Needs
The list comprises 34 drugs and 37 devices that address urgent clinical needs. It includes 23 drugs and 28 devices under the “Hong Kong-Macau Drug and Device Access” policy, which is part of the GBA initiative to provide patients with access to drugs across the region. Additionally, 4 drugs are designated by the National Medical Products Administration (NMPA) as clinically urgent overseas new drugs.

New Entrants on the List

NO.Generic NameIndicationMAHSpecificationPacking Specification
1RomosozumabTreatment of severe osteoporosis in postmenopausal women at high risk of fractures.AMGEN HONG KONG LIMITED105mg/1.17ml/shot2 shots/box
2Follitropin alfa/Lutropin alfaTreatment of adult female patients with severe deficiency of LH and FSH.MERCK PHARMACEUTICAL(HK) LIMITED450IU/225IU, 0.72mL1 pre-filled injection pen/box
3Follitropin alfa/Lutropin alfaSame as above.MERCK PHARMACEUTICAL(HK) LIMITED150 IU/75 IU1 bottle of powder and 1 bottle of solvent/box
4EptinezumabPrevention of migraines in adults experiencing migraine attacks at least 4 days a month.LUNDBECK HK LIMITED100mg/1mL1ml/bottle, 1 bottle/box
5EtrasimodTreatment of moderate to severe active ulcerative colitis in patients aged 16 and above.Everest Medicines (Singapore) Pte. Ltd.2mg/tablet30 tablets/bottle
6Elosulfase alfaTreatment of patients with type IVA mucopolysaccharidosis (MPS IVA, Morquio A syndrome).BIOMARIN PHARMACEUTICAL INC.5mg/5mL (1mg/1mL)1 bottle/box
7Tisotumab vedotinTreatment of recurrent or metastatic cervical cancer in adults.Seagen Inc.40mg1 shot/bottle
New Entrants on List of urgently needed Hong Kong and Macau drugs and medical devices for clinical use in nine cities in the Guangdong Hong Kong Macao Greater Bay Area (2024)

-Fineline Info & Tech

Insight, China's Pharmaceutical Industry